Does radiotherapy increase oxidative stress? A study with nasopharyngeal cancer patients revealing anomalies in isoprostanes measurements

Free Radical Research

Volumn 44, Issue 9, 2010, Pages 1064-1071

  Lim, Keith H C ^a   Lee, Chung Yung J ^b   Earnest, Arul ^c   Seet, Raymond C S ^b   Halliwell, Barry ^b  

^a Singapore   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

free radicals; Isoprostanes; nasopharyngeal cancer; radiotherapy

Indexed keywords

ARACHIDONIC ACID; CISPLATIN; F2 ISOPROSTANE; ISOPROSTANE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATITIS; HUMAN; INTENSITY MODULATED RADIATION THERAPY; IONIZING RADIATION; LOW DRUG DOSE; MALE; MUCOSA INFLAMMATION; NASOPHARYNX CANCER; NEUTROPENIA; OXIDATIVE STRESS; RADIATION EXPOSURE; SEPSIS; SIDE EFFECT; URINALYSIS; WEIGHT REDUCTION; XEROSTOMIA;

ADULT; AGED; CARCINOMA; DOSE FRACTIONATION; F2-ISOPROSTANES; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; OXIDATIVE STRESS; RADIATION INJURIES; RADIOTHERAPY; UP-REGULATION;

EID: 77956362404     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2010.499906     Document Type: Article

References (21)

1. Von Sonntag C. Free radical-induced DNA damage and its repair: a chemical perspective. Basel: Springer; 2006.
2. Biaglow JE, Mitchell JB, Held K. The importance of peroxide and superoxide in the X-ray response. Int J Radiat Oncol Biol Phys 1992;22:665-669.
3. Peters LJ. Inherent radiosensitivity of tumour and normal tissue cells as a predictor of human tumour response. Radiother Oncol 1990;17:177-190.
4. th ed), UK; 2007.
5. 2-isoprostanes: unique bioactive products of lipid peroxidation. Prog Lipid Res 1997;36:1-21.
6. Lee CYJ, Seet R, Huang SH, Long LH, Halliwell B. Different patterns of oxidized lipid products in plasma and urine of dengue fever, stroke and Parkinsons disease patients. Cautions in the use of biomarkers of oxidative stress. Antiox Redox Signal 2009;11:407-420.
7. Montuschi P, Peter JB, Roberts LJ. Isoprostanes: markers and mediators of oxidative stress. FASEB 2004;18:1791-1800.
8. Halliwell B. Oxidative stress and cancer: have we moved forward? Biochem J 2007;401:1-11.
9. Keaney JF, Jr, Larson MG, Vasan RS, Wilson PW, Lipinska I, Corey D, Massaro JM, Sutherland P, Vita JA, Benjamin EJ. Framingham Study. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol. 2003;23:434-439.
10. Camphausen K, Menard C, Sproull M, Goley E, Basu S, Coleman CN. Isoprostane levels in the urine of patients with prostate cancer receiving radiotherapy are not elevated. Int J Radiat Oncol Biol Phys 2004;58:1536-1539.
11. Park EM, Ramnath N, Yang GY, Ahn JY, Park Y, Lee TY, Shin HS, Yu J, Ip C, Park YM. High superoxide dismutase and low glutathione peroxidase activities in red blood cells predict susceptibility of lung cancer patients to radiation pneumoni-tis. Free Radic Biol Med 2007;42:280-287.
12. Meyer F, Bairati I, Fortin A, G é linas M, Nabid A, Brochet F, T ê tu B. Interaction between antioxidant vitamin supplementation and cigarette smoking during radiation therapy in relation to long-term effects on recurrence and mortality: a randomized trial among head and neck cancer patients. Int J Cancer 2008;122:1679-1683.
13. Bairati I, Meyer F, G é linas M, Fortin A, Nabid A, Brochet F, Mercier JP, T ê tu B, Harel F, Ardous B, Vineault E, Vass S, Del Vecchio P, Roy J. Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients. J Clin Oncol 2005;23:5805-5813.
14. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 1990;87:9383-9387.
15. 2-isoprostanes, hydroxyeicosatetraenoic products, and oxysterols from a single plasma sample. Free Radic Biol Med 2008; 44:1314-1322.
16. 2-isopros-tanes by gas chromatography-mass spectrometry. Biochem Biophys Res Commun 2004;320:696-702.
17. Zeger SL, Liang K Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;42:121-130.
18. Barker JL, Garden AS, Ang KK, O' Daniel JC, Wang H, Court LE, Morrison WH, Rosenthal DI, Chao KS, Tucker SL, Mohan R, Dong L. Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head and neck cancer using an integrated CT/linear accelerator system. Int J Radiation Oncology Biol Phys 2004;59: 960-970.
19. Halliwell B, Lee CYJ. Using isoprostanes as biomarkers of oxidative stress. Some rarely-considered issues. Antiox Redox Signal 2010;13:145-156.
20. 2-isoprostanes but enhances inflammatory cytokine response in a mouse model of ovalbumin-induced allergic lung inflammation. Free Radic Biol Med 2009;47:622-628.
21. 2-isoprostanes in humans: implications for the cardiovascular risk factor cluster. J Hypertens 2002;20:1215-1221.